help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, L. J.
Right arrow Articles by Lazarus, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, L. J.
Right arrow Articles by Lazarus, L.

Endocrinology, Vol 115, 1625-1632, Copyright © 1984 by Endocrine Society


ARTICLES

The mouse fibroblast growth hormone receptor: ligand processing and receptor modulation and turnover

LJ Murphy and L Lazarus

The recent observation that adipose conversion of mouse 3T3 fibroblasts is stimulated by physiological concentrations of human GH (hGH) and rat GH in vitro suggested that this cell line may be suitable for the study of GH-receptor interactions. The aim of this study was to examine the binding and subsequent processing of [125I]iodo-hGH by BALB/c 3T3 mouse fibroblasts. Binding of [125I]iodo-hGH to 3T3 fibroblasts was time and temperature dependent. Apparent steady state binding was achieved after 1 and 2 h at 37 and 30 C, respectively. At 37, 30, and 20 C specifically bound [125I]iodo-hGH became increasingly resistant to removal by acid treatment (0.15 M NaCl/0.05 M glycine, pH 2.5). In contrast at 4 C or at higher temperatures in the presence of metabolic inhibitors, a greater proportion of specifically bound hGH was removed by acid treatment. Inclusion of 0.2 mM chloroquine in the incubation medium resulted in significantly more accumulation of trichloroacetic acid (TCA)-precipitable radioactivity compared to control cells without affecting the shift of radioactivity from the acid-elutable to the acid- inaccessible compartment. After removal of [125I]iodo-hGH from the medium there was a rapid loss of radioactivity (t 1/2 = 36.5 +/- 7.2 min, SE, n = 3) from the cell monolayer with a concomitant appearance in the medium of TCA-soluble radioactive species. Chloroquine reduced the rate of efflux of radioactivity from the monolayer (t 1/2 = 4.5 +/- 0.6 h, n = 3) and the appearance of TCA-soluble material in the medium. The half-time of GH receptor loss after inhibition of protein synthesis with cycloheximide (0.1 mM) was 1.25 +/- 0.14 h, n = 3). In contrast half-time of net receptor synthesis calculated from the recovery of specific [125I]iodo-hGH binding capacity after ligand-induced down- regulation was 10.2 +/- 1.5 h, n = 3). These data reveal that after binding of [125I]iodo-hGH to specific cell surface receptors there is rapid irreversible binding of GH to its receptor with a resultant reduction in receptor concentration. Degradation of [125I]iodo-hGH occurs intracellularly and involves processes which are inhibited by lysosomotropic agents. On the basis of these studies we conclude that the binding and subsequent processing of GH by 3T3 fibroblasts is qualitatively similar to that described for other polypeptide hormones and growth factors in this and other cell lines.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. Gent, M. van den Eijnden, P. van Kerkhof, and G. J. Strous
Dimerization and Signal Transduction of the Growth Hormone Receptor
Mol. Endocrinol., May 1, 2003; 17(5): 967 - 975.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Gent, P. van Kerkhof, M. Roza, G. Bu, and G. J. Strous
Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis
PNAS, July 23, 2002; 99(15): 9858 - 9863.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. van Kerkhof, M. Smeets, and G. J. Strous
The Ubiquitin-Proteasome Pathway Regulates the Availability of the GH Receptor
Endocrinology, April 1, 2002; 143(4): 1243 - 1252.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. van Kerkhof, C. M. A. dos Santos, M. Sachse, J. Klumperman, G. Bu, and G. J. Strous
Proteasome Inhibitors Block a Late Step in Lysosomal Transport of Selected Membrane but not Soluble Proteins
Mol. Biol. Cell, August 1, 2001; 12(8): 2556 - 2566.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Sachse, P. van Kerkhof, G. J. Strous, and J. Klumperman
The ubiquitin-dependent endocytosis motif is required for efficient incorporation of growth hormone receptor in clathrin-coated pits, but not clathrin-coated lattices
J. Cell Sci., January 11, 2001; 114(21): 3943 - 3952.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. van Kerkhof, R. Govers, C. M. Alves dos Santos, and G. J. Strous
Endocytosis and Degradation of the Growth Hormone Receptor Are Proteasome-dependent
J. Biol. Chem., January 21, 2000; 275(3): 1575 - 1580.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. Strous and R Govers
The ubiquitin-proteasome system and endocytosis
J. Cell Sci., January 5, 1999; 112(10): 1417 - 1423.
[Abstract] [PDF]


Home page
EndocrinologyHome page
C. Jux, K. Leiber, U. Hugel, W. Blum, C. Ohlsson, G. Klaus, and O. Mehls
Dexamethasone Impairs Growth Hormone (GH)-Stimulated Growth by Suppression of Local Insulin-Like Growth Factor (IGF)-I Production and Expression of GH- and IGF-I-Receptor in Cultured Rat Chondrocytes
Endocrinology, July 1, 1998; 139(7): 3296 - 3305.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Govers, P. van Kerkhof, A. L. Schwartz, and G. J. Strous
Di-leucine-mediated Internalization of Ligand by a Truncated Growth Hormone Receptor Is Independent of the Ubiquitin Conjugation System
J. Biol. Chem., June 26, 1998; 273(26): 16426 - 16433.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K.-C. Leung and K. K. Y. Ho
Stimulation of Mitochondrial Fatty Acid Oxidation by Growth Hormone in Human Fibroblasts
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4208 - 4213.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-C. Leung, M. J. Waters, I. Markus, W. R. Baumbach, and K. K. Y. Ho
Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: A novel mechanism of growth hormone receptor regulation
PNAS, October 14, 1997; 94(21): 11381 - 11386.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P.J. King, M.-J. Tseng, C. D. Logsdon, N. Billestrup, and C. Carter-Su
Distinct Cytoplasmic Domains of the Growth Hormone Receptor Are Required for Glucocorticoid- and Phorbol Ester-induced Decreases in Growth Hormone (GH) Binding. THESE DOMAINS ARE DIFFERENT FROM THAT REPORTED FOR GH-INDUCED RECEPTOR INTERNALIZATION
J. Biol. Chem., July 26, 1996; 271(30): 18088 - 18094.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. A. dos Santos, P. van Kerkhof, and G. J. Strous
The Signal Transduction of the Growth Hormone Receptor Is Regulated by the Ubiquitin/Proteasome System and Continues After Endocytosis
J. Biol. Chem., March 30, 2001; 276(14): 10839 - 10846.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Alves dos Santos, T. ten Broeke, and G. J. Strous
Growth Hormone Receptor Ubiquitination, Endocytosis, and Degradation Are Independent of Signal Transduction via Janus Kinase 2
J. Biol. Chem., August 24, 2001; 276(35): 32635 - 32641.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society